Large Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization
Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $155B | $285.61 | 0.82% |
|
2
Gilead Sciences
GILD
$141B
| $141B | $112.56 | 1.19% |
|
3
Pfizer
PFE
$140B
| $140B | $24.60 | 1.87% |
|
4
Sanofi
SNY
$122B
| $122B | $49.94 | 0.34% |
|
5
Bristol-Myers Squibb
BMY
$96.9B
| $96.9B | $46.88 | 1.57% |
|
6
GSK
GSK
$79.5B
| $79.5B | $39.44 | 1.18% |
|
7
Biogen
BIIB
$20B
| $20B | $132.65 | 2.72% |
|